The emerging treatment of tirzepatide peptide represents a major development in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide379814.blogacep.com/47741512/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment